Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WJ-MSC in chronic traumatic cervical incomplete spinal cord injury
NCT05054803Phase 2Completed
- Sponsor
- Banc de Sang i Teixits
- Start
- Oct 2021
- Primary completion
- Jan 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of wharton's jelly mesenchymal stromal cells in Spinal cord injury (SCI), sponsored by Banc de Sang i Teixits. Started Oct 2021; status: completed.
02
Drugs
wharton's jelly mesenchymal stromal cells
03
Conditions
Spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT05054803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05054803.